Figure 3.
CCR6+ IL-17+ Il4R576 Treg cells exhibit instability and compromised suppressive activity (a) Methylation status of CpG motifs in Treg cells isolated from lung tissue of OVA–sensitized and challenged mice. Numbers on the left side indicate the position of the respective motifs. (b) Global methylation status of Foxp3 CNS2 in the respective Treg cell populations (n = 3 mice per group with 7-12 clones per mouse). (c) In vitro suppression of the proliferation of WT responder CD4+ T cells (Teff) by the respective Treg cell populations (n = 3 replicates per group) (d) Gene expression profiles (volcano plot) of EGFP+CCR6− versus EGFP+CCR6+ Treg cells isolated by FACS from lung digests of OVA-sensitized and challenged Foxp3EGFP Il4R576 mice (n = 3–4 mice). FDR: false discovery rate; Log2FC: Log2 fold change. (e) Flow cytometric analysis and frequencies of exTreg (GFP−YFP+) cells, plotted as a fraction of exTreg to total Treg cells in lung tissue. (f,g) Flow cytometric analysis and frequencies of CCR6 producing (f) and IL-17 and IL-13 producing (g) exTreg cells in lung tissues. (h) Flow cytometric analysis and frequencies of exTreg and Treg cells among CD4+IL-17+ Tconv cells in lung tissues of the respective mouse groups (n = 6 mice for PBS- and 9 mice for OVA-treated groups for e–h). Data represent means ± s.e.m. from two independent experiments. *P < 0.05, **P < 0.005 and ****P < 0.0001 by one-way ANOVA with Bonferroni posttest analysis. For suppression assay ****P < 0.0001 by repeated measures two-way ANOVA.